1. Long-Term Safety and Efficacy of a Combination of Niacin Extended Release and Simvastatin in Patients with Dyslipidemia

   • Richard H. Karas
   • Moti L. Kashyap
   • Michael H. Davidson

   Original Research Article 20 August 2012 Pages: 69 - 81

   

2. Comparison of Efficacy of Low- (80 mg/day) and High- (160–320 mg/day) Dose Valsartan in the Prevention of In-Stent Restenosis after Implantation of Bare-Metal Stents in Type B2/C Coronary Artery Lesions

   • Stefan Peters

   Original Research Article 20 August 2012 Pages: 83 - 87

   

3. Which Strategy Is More Effective for the Treatment of Cardiovascular Disease

   • Shin-ichiro Miura
   • Keijiro Saku

   Commentary 20 August 2012 Pages: 88 - 90

4. Aspirin and Platelet Adenosine Diphosphate Receptor Antagonists in Acute Coronary Syndromes and Percutaneous Coronary Intervention

   • Jeremiah P. Depta
   • Deepak L. Bhatt

   Review Article 20 August 2012 Pages: 91 - 112

   

5. Fondaparinux Sodium

   • Stephanie K. A. Blick
   • Jennifer S. Orman
   • Lesley J. Scott

   Adis Drug Evaluation 20 August 2012 Pages: 113 - 125

   

6. Rosuvastatin

   • Gillian M. Keating
   • Dean M. Robinson

   Adis Drug Evaluation 20 August 2012 Pages: 127 - 146